The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Statement 4.2
“All prescriptions should be reviewed and validated as soon as possible by a hospital pharmacist. Whenever the clinical situation allows, this review should take place prior to the supply and administration of medicines.”
What does it mean for patients? Patients can rely on hospital pharmacists as they contribute to reducing the risk of medication errors. Hospital pharmacists also contribute to the appropriate use of medicines to reach the optimal patient outcomes by monitoring all patients receiving treatment
What does it mean for healthcare professionals? Healthcare professionals can rely on hospital pharmacists to contribute to reduce the risk of medication errors. They also contribute to the appropriate use of medicines by providing advice regarding the medication therapy as well as monitoring the patients
What does it mean for Hospital Pharmacists? Hospital Pharmacists should systematically review and validate all prescriptions prior to dispensing and administration of medication Hospital Pharmacists should contribute in the definition of procedures for correct prescription and administration of medicines. Hospital pharmacists should continue to monitor all patients who receive medicines to ensure appropriate medication use and optimal outcomes.
The Tyne and Wear NHS Foundations Trust Hospital is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
- PROGRAMME OF PHARMACOTHERAPEUTIC BENEFIT TO THE SOCIO-SANITARY CENTRES OF A SPECIFIC HEALTH AREA THROUGH THE HOSPITAL PHARMACY SERVICE
- INTEGRATION OF THE CLINICAL PHARMACIST IN A MULTIDISCIPLINARY TEAM IN A BURNS UNIT
- GPI: DEFINING DOSAGE REGIMENS OF ERLOTINIB AND GEFITINIB IN NON-SMALL CELL LUNG CANCER PATIENTS USING MODELLING AND SIMULATION
- USING AN ELECTRONIC ALGORITHM TO IDENTIFY THE MOST RELEVANT PATIENTS FOR MEDICATION REVIEW
- MPLEMENTATION OF A NEW CLINICAL PHARMACY SERVICE WITHIN A NEWLY LAUNCHED SURGICAL ADMISSIONS PROCESS
- Clinical pharmacy›Discharge prescription Clinical pharmacy›Patient discharge Drug prescribing and dosing›Prescribing error
- EAHP Survey results 2016/2017 (sections 1,3 and 4)
- EAHP Survey Report 2015
- GPI: PIM-CHECK: Development of the first electronic prescription-screening checklist to support healthcare professionals in the detection of potentially inappropriate medication
- GPI: Discharge Management: Safer Discharges and Improved Information Transfer Metrics
- GPI: Medication reviews conducted by clinical pharmacist in emergency ward
- EAHP Brochure